Bayer plans a pharmaceutical campus in New Albany

New Albany investment plan

Bayer announced a $2.2 billion pharmaceutical campus in Ohio on 2 October 2026. Manufacturing Dive reported the plan on 6 October.

Drug substance module: operations expected in 2031.
Drug product module: planned for 2034.
Around 600 permanent jobs and 1,500 construction jobs anticipated.

Workforce training in Ohio

Ohio Life Sciences said on 2 October that Bayer would use the Ohio Life Science Training Center to prepare operators and technicians. The $35 million centre was under construction in New Albany, with opening scheduled for summer 2027. The association reported $1.5 million in state capital funding and a JobsOhio investment of up to $30 million in the centre. It credited industry partners with shaping training requirements and identified Columbus State Community College among the higher education partners. Association president Eddie Pauline attributed the investment decision partly to the state's preparations for a trained workforce.

Berkeley facility opened in October 2023

Bayer announced a $250 million, 100,000-square-foot cell therapy facility opened in Berkeley on 10 October 2023. The company described capacity for late-stage trials and potential commercial launches, with space for a second production module. It identified the building as its first fully electric pharmaceutical manufacturing plant. Fluor's 18 October completion announcement listed engineering, procurement, construction management, commissioning, qualification and validation among its responsibilities. Fluor said phased construction allowed start-up activities to begin according to the production timetable. The contractor had also completed the campus's Cell Culture Technology Center in 2021.

Consumer Health expansion in April 2025

On 16 April 2025, Bayer celebrated a 70,000-square-foot addition to its Myerstown, Pennsylvania facility, following a $44 million investment announced for 2022. The company described eight new packaging lines and automated logistics systems intended to improve product movement. The site, whose history stretches back more than 75 years, was identified as the largest in Bayer's worldwide Consumer Health manufacturing network. Its products included Bayer Aspirin, Aleve and Claritin. Bayer also outlined digital skills development for employees and plans to invite local high school educators to visit the plant and share information with their school districts.